自主创新药企商标遭“狙击”,浙江孚诺医药“硬刚”美国能源巨擘

泰山财经
Jun 12, 2025

泰山财经记者丁一凡实习记者赵诗婕近日,泰山财经注意到,浙江一家创新药物企业浙江孚诺医药股份有限公司(以下简称“孚诺医药”)自主研发的创新药物——新一代黄褐斑外用药“孚美达”自去年5月上市后,便接连被美国能源企业埃克森美孚(Exxon Mobil Corporation,以下简称“美孚”)以“商标近似”为由发起的无效宣告请求。一边是主营能源业务的跨国企业,另一边则是浙江的创新药企,看似行业、领域完全...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10